Patents by Inventor Elisabeth Traiffort

Elisabeth Traiffort has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of demyelinating diseases
    Patent number: 11723911
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: August 15, 2023
    Assignee: M ET P PHARMA AG
    Inventors: Claudia Mattern, Elisabeth Traiffort, Michael Schumacher
  • TREATMENT OF DEMYELINATING DISEASES
    Publication number: 20210283143
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Application
    Filed: January 25, 2021
    Publication date: September 16, 2021
    Applicant: M ET P PHARMA AG
    Inventors: Claudia MATTERN, Elisabeth TRAIFFORT, Michael SCHUMACHER
  • Treatment of demyelinating diseases
    Patent number: 10898495
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: January 26, 2021
    Assignee: M ET P PHARMA AG
    Inventors: Claudia Mattern, Elisabeth Traiffort, Michael Schumacher
  • TREATMENT OF DEMYELINATING DISEASES
    Publication number: 20200206244
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Applicant: M ET P PHARMA AG
    Inventors: Claudia MATTERN, Elisabeth TRAIFFORT, Michael SCHUMACHER
  • Treatment of demyelinating diseases
    Patent number: 10596181
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: March 24, 2020
    Assignee: M ET P PHARMA AG
    Inventors: Claudia Mattern, Elisabeth Traiffort, Michael Schumacher
  • TREATMENT OF DEMYELINATING DISEASES
    Publication number: 20190328750
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Application
    Filed: July 9, 2019
    Publication date: October 31, 2019
    Applicant: MET P PHARMA AG
    Inventors: Claudia MATTERN, Elisabeth TRAIFFORT, Michael SCHUMACHER
  • N-acylthiourea and N-acylurea inhibitors of the Hedgehog protein signalling pathway
    Patent number: 9073835
    Abstract: The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the Hedgehog protein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: July 7, 2015
    Assignees: Centre National De La Recherche Scientifique, Universite De Strasbourg
    Inventors: Martial Ruat, Hélène Faure, Elisabeth Traiffort, Angèle Schoenfelder, André Mann, Maurizio Taddei, Antonio Solinas, Fabrizio Manetti
  • Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
    Patent number: 8889678
    Abstract: The present invention relates to acyl guanidine derivatives modulating the hedgehog protein signaling pathway to be used as drugs, in particular for treating diseases involving a tissue dysfunction associated with a deregulation of the hedgehog protein signaling pathway, as well as to pharmaceutical compositions containing same. The present invention also relates to novel acyl guanidine derivatives as such.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: November 18, 2014
    Assignees: Centre National de la Recherche Scientifique, Universite de Strasbourg
    Inventors: Martial Ruat, Hélène Faure, Elisabeth Traiffort, Hermine Roudaut, André Mann, Angèle Schoenfelder, Maurizio Taddei, Fabrizio Manetti, Antonio Solinas
  • Use of mifepristone and derivatives therefor as Hedgehog protein signaling pathway modulators and applications of same
    Patent number: 8703752
    Abstract: The invention relates to a novel use of compounds having formula (I), including mifepristone (RU 486 or RU 38 486) and the derivative salts thereof, for the preparation of a medicament that can modulate (activate or inhibit) the Hedgehog protein signalling pathway, which is intended for the treatment of pathologies involving a tissue dysfunction linked to deregulation of said pathway.
    Type: Grant
    Filed: January 22, 2004
    Date of Patent: April 22, 2014
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Martial Ruat, Elisabeth Traiffort, Hélène Faure
  • Acyl Guanidine Derivatives Modulating The Hedgehog Protein Signaling Pathway
    Publication number: 20120196865
    Abstract: The present invention relates to acyl guanidine derivatives modulating the hedgehog protein signaling pathway to be used as drugs, in particular for treating diseases involving a tissue dysfunction associated with a deregulation of the hedgehog protein signaling pathway, as well as to pharmaceutical compositions containing same. The present invention also relates to novel acyl guanidine derivatives as such.
    Type: Application
    Filed: July 19, 2010
    Publication date: August 2, 2012
    Applicants: UNIVERSITE DE STRASBOURG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Martial Ruat, Hélène Faure, Elisabeth Traiffort, Hermine Roudaut, André Mann, Angèle Schoenfelder, Maurizio Taddei, Fabrizio Manetti, Antonio Solinas
  • N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
    Publication number: 20110275663
    Abstract: The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the Hedgehog protein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical compositions containing them.
    Type: Application
    Filed: April 16, 2009
    Publication date: November 10, 2011
    Inventors: Martial Ruat, Hélène Faure, Elisabeth Traiffort, Angèle Schoenfelder, André Mann, Maurizio Taddei, Antonio Solinas, Fabrizio Manetti
  • Choline transport like (CTL) membrane proteins involved in choline transport
    Patent number: 7303895
    Abstract: The invention concerns the identification of a novel family of CTL (Choline Transporter Like) genes, in particular hCTL1 and hCTL2, involved in the metabolism and/or transport of choline in cells such as the intestinal tract cells, nervous cells, in particular motoneurons, sensitive neurons, neurons of the nucleus dorsalis of the spinal cord and oligodendrocytes. The invention opens up new prospects in particular for the treatment of familial dysautonomia, and Tangier disease. More generally, the identification of CTL genes enables to develop new strategies for treating diseases of the nervous system, in particular neurodegenerative demyelenating diseases, particularly Alzheimer disease, Parkinson disease and Huntington disease.
    Type: Grant
    Filed: November 3, 2000
    Date of Patent: December 4, 2007
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Seana O'Regan, François Meunier, Elisabeth Traiffort, Martial Ruat
  • Novel use of mifepristone and derivatives therefor as hedgehog protein signaling pathway modulators and applications of same
    Publication number: 20070060546
    Abstract: The invention relates to a novel use of compounds having formula (I), including mifepristone (RU 486 or RU 38 486) and the derivative salts thereof, for the preparation of a medicament that can modulate(activate or inhibit) the Hedgehog protein signalling pathway, which is intended for the treatment of pathologies involving a tissue dysfunction linked to deregulation of said pathway.
    Type: Application
    Filed: January 22, 2004
    Publication date: March 15, 2007
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIF
    Inventors: Martial Ruat, Elisabeth Traiffort, Helene Faure